Navigating the Nexus: Why Maritime Law and Public Health Are One Field, Not Two

On any given day roughly 1.89 million seafarers are at sea aboard some 74,000 vessels, moving the goods that make up more than 80 percent of world trade. The oceans they work feed more than three billion people. And the law that governs their health, and the public-health systems meant to protect it, have run on entirely separate tracks, maritime law, flag-State jurisdiction, and port inspection on one; epidemiology, health policy, and environmental health on the other. The dialogue between them has been occasional, not structural. That separation is not intellectually defensible, and the cost of it is a governance gap where legal duties with real health content go underenforced.

The argument is straightforward: the major instruments of maritime governance already contain substantive public-health obligations, they are simply not administered by anyone with public-health expertise. UNCLOS Part XII obliges States to prevent, reduce, and control marine pollution, language that reads directly onto ballast-water pathogens, methylmercury in fish, and harmful algal blooms. The International Health Regulations define ports as designated points of entry with mandatory health-capacity requirements. The Maritime Labour Convention sets standards for medical care, fitness for duty, and repatriation. Three treaties, three bodies of public-health law, administered as if they were anything but.

The case becomes concrete across three domains. The first is seafarer occupational health, where elevated mortality and depression rates collide with a fatigue regime that is legally mandated yet routinely falsified. The second is infectious disease at the maritime border: the Diamond Princess, where 712 of 3,711 aboard were infected, was a legal failure as much as a public-health one, no one had a settled answer to whose jurisdiction applied, and molecular work has since traced viral spread along specific cruise itineraries, confirming shipping routes as conduits for disease. The third is environmental: methylmercury, algal toxins, and climate-driven declines in fish nutrition are population-health problems governed by maritime treaties that no health ministry engages with on those terms.

COVID-19 served as proof of concept in both directions. Both treaties were reformed in direct response, the IHR amendments adopted in 2024 and in force since September 2025, and the MLC's 2022 amendments in force since December 2024, bringing key-worker recognition, stronger repatriation, connectivity provisions, and a seafarer death register. The reforms are real, and they are incomplete in a revealing way: each identified exactly the failures a public-health lens would predict, and each fell short precisely because public-health expertise was never embedded in the negotiating architecture. (That fragmentation is compounded by the eleven States, including the United States, that rejected the IHR amendments outright.) Incremental legal revision without disciplinary integration, in short, keeps reproducing the same gap.

What the paper proposes is not special treatment but a name and a structure: maritime public health established as a formal interdisciplinary field, with health impact assessment built into treaty processes, standardized health surveillance extended to maritime entry points, and an institutional home within the WHO–IMO–ILO tripartite system. For regulators, that is the institutional fix. For P&I and counsel, it is the recognition that health duties at sea are legal duties, and that enforcement exposure and liability live exactly in the gap between the two fields.

This nexus is the foundation the whole practice rests on. Plimsoll Analytics works at the point where public health and the law of the sea meet — fluent in both languages, because the problems do not respect the border between them.